Pini L A, Bigarelli M, Vitale G, Sternieri E
Headache Study Center, Servizio di Tossicologia a Farmacologia Clinica dell'Universitá di Modens, Italy.
Headache. 1996 Jul-Aug;36(7):433-9. doi: 10.1046/j.1526-4610.1996.3607433.x.
We evaluated 102 patients attending the Headache Study Center of the University of Modena who were suffering from chronic daily headache with daily drug intake. Patients underwent either day hospital treatment followed by a standard prophylactic therapy or they started prophylactic therapy immediately. After 30 and 120 days, both the Headache index and the daily drug intake had significantly improved (P < 0.001), and there were no differences in reduction of mean values of the Headache index or daily drug intake with respect to the two treatments, nor with regard to the prophylactic therapy chosen. Twenty-eight percent of patients reverted to daily drug intake after a 4-month follow-up; these patients took barbiturate-containing mixtures in a higher percentage than other drugs, and within the group of relapsing patients the outpatients relapsed to analgesic intake more than the day hospital-treated patients (P < 0.05).
我们评估了102名前往摩德纳大学头痛研究中心就诊的患者,他们患有慢性每日头痛且每日都要服药。患者要么先接受日间医院治疗,随后进行标准预防性治疗,要么立即开始预防性治疗。30天和120天后,头痛指数和每日药物摄入量均有显著改善(P < 0.001),两种治疗方法在头痛指数平均值或每日药物摄入量的降低方面没有差异,所选的预防性治疗方法之间也没有差异。4个月的随访后,28%的患者恢复了每日服药;这些患者服用含巴比妥酸盐混合物的比例高于其他药物,在复发患者组中,门诊患者比日间医院治疗的患者更容易复发止痛药摄入(P < 0.05)。